Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Celera Diagnostics To Open Genotyping Facility
Celera Diagnostics, a $300 million joint venture of Celera Genomics and Applied Biosystems, will open an industrial-scale facility to perform high-volume genotyping and gene expression research. Applied Biosystems, a manufacturer of gene sequencing hardware, is currently expanding at a building in the Hacienda Business Park in Pleasanton, Calif., where renovations will be completed around the end of fiscal 2002. Celera Genomics and Applied Biosystems are both owned by Applera.
Maricopa County Medical Examiner Builds New Office
Maricopa County Medical Examiner office and parking structure recently broke ground. The St. Louis firm HERA Inc. provided lab planning for the 62,000-sf facility as part of the team led by The Stichler Group in Phoenix. The facility, programmed for a staff of 114, features autopsy suites, DNA and trace evidence labs, and pathology, toxicology, histology and forensic science labs.
CDC To Build Infectious Diseases Lab
The Centers for Disease Control and Prevention is preparing to begin construction of the $132 million Emerging Infectious Diseases Laboratory. The lab will house multiple research activities, providing approximately 370,000 gsf of research space for 459 personnel. The project scope includes a ten-story tower containing a combination of labs, lab support, and scientific personnel workstations. An attached five-story structure will house specialized lab spaces. Together, the labs will accommodate Biosafety Level 2, 3, and 4 work.
DFI Group Plans Ethanol R&D Center
DFI Group Inc., a commercial and industrial developer, is considering a site in the Charlotte, N.C., area to build an ethanol R&D center. An existing building in Monroe is under consideration. A section of the multimillion-dollar facility would be designed to produce 3 million gallons of ethanol annually. DFI Construction Inc., formed this year, supports the company’s industrial project construction needs in the Southeast.
Dow Chemical Plans Biotech Contract Manufacturing Plant
Dow Chemical Co., based in Midland, Mich., is planning to transform a 55,000-sf facility previously occupied by Collaborative Group Ltd.’s Biotechnology Services Division into a large-molecule drugs contract manufacturing plant to serve the biotech industry. The facility will have a 50,000-liter capacity. World-wide, the capacity to produce large-molecule drugs stands at about 380,000 liters, with a critical shortage of capacity anticipated by 2005.